BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38263886)

  • 1. Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
    Booth N; Ngwube A; Appavu B; Shah S; Abruzzo T
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38263886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.
    Carpenter JL; Nickel RS; Webb J; Khademian Z; Speller-Brown B; Majumdar S; Darbari DS; Campbell A; Zhang A; Abraham A
    Transplant Cell Ther; 2021 Dec; 27(12):1018.e1-1018.e9. PubMed ID: 34530179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.
    Hulbert ML; Fields ME; Guilliams KP; Bijlani P; Shenoy S; Fellah S; Towerman AS; Binkley MM; McKinstry RC; Shimony JS; Chen Y; Eldeniz C; Ragan DK; Vo K; An H; Lee JM; Ford AL
    Blood; 2023 Jan; 141(4):335-344. PubMed ID: 36040484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia.
    Amlie-Lefond C; Flanagan J; Kanter J; Dobyns WB
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2897-2904. PubMed ID: 30076115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management.
    Guilliams KP; Kirkham FJ; Holzhauer S; Pavlakis S; Philbrook B; Amlie-Lefond C; Noetzel MJ; Dlamini N; Sharma M; Carpenter JL; Fox CK; Torres M; Ichord RN; Jordan LC; Dowling MM
    Stroke; 2019 May; 50(5):1089-1094. PubMed ID: 31009343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients.
    de Azevedo JTC; Costa TCM; Lima KC; Maciel TT; Palma PVB; Darrigo-Júnior LG; Setanni Grecco CE; Stracieri ABPL; Elias JB; Pieroni F; Guerino-Cunha RL; Pinto ACS; De Santis GC; Covas DT; Hermine O; Simões BP; Oliveira MC; Malmegrim KCR
    Front Immunol; 2021; 12():774442. PubMed ID: 34956203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
    Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
    Furstenau DK; Tisdale JF
    Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of a proposed study of hematopoietic stem cell transplant for children with "less severe" sickle cell disease.
    Nickel RS; Hendrickson JE; Haight AE
    Blood; 2014 Aug; 124(6):861-6. PubMed ID: 24963044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.
    Meier ER; Abraham AA; Ngwube A; Janson IA; Guilcher GMT; Horan J; Kasow KA
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28861. PubMed ID: 33405370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?
    Flor-Park MV; Ozahata MC; Moura ICG; Blatyta P; Kelly S; Oliveira CDL; Capuani L; Belisário AR; Carneiro-Proietti ABF; Araujo AS; Loureiro P; Maximo C; Rodrigues DOW; Mota RA; Sabino E; Custer B; Rocha V;
    Transplant Cell Ther; 2022 Oct; 28(10):708.e1-708.e8. PubMed ID: 35788087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort.
    Flor-Park MV; Kelly S; Preiss L; Custer B; Carneiro-Proietti ABF; Araujo AS; Loureiro P; Maximo C; Rodrigues DOW; Mota RA; Sabino EC; Rocha V;
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2103-2109. PubMed ID: 31229639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5 years after HSCT].
    Bockenmeyer J; Chamboredon E; Missud F; Benkerrou M; Holvoët L; Ithier G; Lescoeur B; Yakouben K; Ouachée-Chardin M; Rohrlich PS; Duval M; Baruchel A; Dalle JH
    Arch Pediatr; 2013 Jul; 20(7):723-30. PubMed ID: 23769628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant.
    Bodas P; Rotz S
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):190-3. PubMed ID: 24327127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions.
    Jang T; Mo G; Stewart C; Khoury L; Ferguson N; Egini O; Muthu J; Dutta D; Salifu M; Lim SH
    Cell Transplant; 2021; 30():9636897211046559. PubMed ID: 34628962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demands and challenges for patients with sickle-cell disease requiring hematopoietic stem cell transplantation in Saudi Arabia.
    Alsultan A; Jastaniah W; Al Afghani S; Al Bagshi MH; Nasserullah Z; Al-Suliman AM; Alabdulaali MK
    Pediatr Transplant; 2016 Sep; 20(6):831-5. PubMed ID: 27477851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study.
    Amlie-Lefond C; Bernard TJ; Sébire G; Friedman NR; Heyer GL; Lerner NB; DeVeber G; Fullerton HJ;
    Circulation; 2009 Mar; 119(10):1417-23. PubMed ID: 19255344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.